Home / Resource Library / Statin therapy with CD19-directed CAR-T therapy improves outcomes in relapsed or refractory large B-cell lymphoma

Statin therapy with CD19-directed CAR-T therapy improves outcomes in relapsed or refractory large B-cell lymphoma

Study examined effect of statins on outcomes in patients with DLBCL receiving CAR-T therapy.